Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hengqing III formula is a traditional Chinese medicine (TCM) multi-herbal formulation, presumably developed as a follow-up or modification of the earlier "Hengqing II" and "Hengqing I" formulas. While direct published data on "Hengqing III" are not found in the provided sources, by analogy to its predecessors, it is likely designed for use in neurodegenerative diseases such as Alzheimer's disease. The mechanism of action for these formulas typically involves modulation of metabolic pathways, improvement of lipid profiles, reduction of homocysteine and inflammatory markers, and possible neuroprotective effects through multiple bioactive plant-derived compounds. The specific herbal composition and pharmacological targets for "Hengqing III" are not detailed in available literature; however, similar TCM formulas often act via antioxidant activity, anti-inflammatory effects, regulation of neurotransmitter levels (such as dopamine), and improvement in cerebral blood flow[1]. The developer is likely an academic or clinical research group specializing in TCM within China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hengqing III formula.